EUA
CovidNow SARS-CoV-2 Assay
FDA Emergency Use Authorization · LMSI, LLC (dba Lighthouse Lab Services) · Oct 14, 2021
Key facts
| Product | CovidNow SARS-CoV-2 Assay |
|---|---|
| Company | LMSI, LLC (dba Lighthouse Lab Services) |
| Product type | Real-time RT-PCR, Home Collection, Screening, Single Target |
| Date | Oct 14, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: